Lichen International (LICN) Competitors $4.88 +0.59 (+13.60%) As of 03:20 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock LICN vs. LDWY, SUGP, WWAC, BIAF, BIYA, DRCT, CDTG, ULY, FTFT, and MSPRShould you be buying Lichen International stock or one of its competitors? The main competitors of Lichen International include Lendway (LDWY), SU Group (SUGP), Worldwide Webb Acquisition (WWAC), bioAffinity Technologies (BIAF), Baiya International Group (BIYA), Direct Digital (DRCT), CDT Environmental Technology Investment (CDTG), Urgent.ly (ULY), Future FinTech Group (FTFT), and MSP Recovery (MSPR). These companies are all part of the "business services" industry. Lichen International vs. Its Competitors Lendway SU Group Worldwide Webb Acquisition bioAffinity Technologies Baiya International Group Direct Digital CDT Environmental Technology Investment Urgent.ly Future FinTech Group MSP Recovery Lichen International (NASDAQ:LICN) and Lendway (NASDAQ:LDWY) are both small-cap business services companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, media sentiment, earnings, institutional ownership, dividends, profitability, risk and valuation. Do institutionals and insiders hold more shares of LICN or LDWY? 6.6% of Lendway shares are owned by institutional investors. 13.2% of Lendway shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Which has more volatility & risk, LICN or LDWY? Lichen International has a beta of 1.08, suggesting that its share price is 8% more volatile than the S&P 500. Comparatively, Lendway has a beta of 2.49, suggesting that its share price is 149% more volatile than the S&P 500. Which has better valuation and earnings, LICN or LDWY? Lendway has lower revenue, but higher earnings than Lichen International. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLichen International$41.48M0.07-$6.14MN/AN/ALendway$37.77M0.24-$5.74M-$2.47-2.09 Is LICN or LDWY more profitable? Lichen International has a net margin of 0.00% compared to Lendway's net margin of -10.37%. Lichen International's return on equity of 0.00% beat Lendway's return on equity.Company Net Margins Return on Equity Return on Assets Lichen InternationalN/A N/A N/A Lendway -10.37%-32.18%-4.54% Does the media refer more to LICN or LDWY? In the previous week, Lendway had 1 more articles in the media than Lichen International. MarketBeat recorded 2 mentions for Lendway and 1 mentions for Lichen International. Lichen International's average media sentiment score of 1.87 beat Lendway's score of 1.43 indicating that Lichen International is being referred to more favorably in the media. Company Overall Sentiment Lichen International Very Positive Lendway Positive SummaryLendway beats Lichen International on 6 of the 11 factors compared between the two stocks. Get Lichen International News Delivered to You Automatically Sign up to receive the latest news and ratings for LICN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LICN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LICN vs. The Competition Export to ExcelMetricLichen InternationalFIN IndustryFinance SectorNASDAQ ExchangeMarket Cap$2.90M$7.73B$12.40B$9.82BDividend YieldN/A4.83%5.58%4.11%P/E RatioN/A19.2719.6825.67Price / Sales0.076.7026.08106.03Price / CashN/A21.1721.5658.93Price / Book0.043.892.246.01Net Income-$6.14M$311.03M$1.00B$264.94M7 Day Performance18.86%3.11%1.99%2.65%1 Month Performance15.21%7.48%1.29%1.49%1 Year Performance-98.83%35.70%544.79%29.16% Lichen International Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LICNLichen InternationalN/A$4.89+13.6%N/A-99.0%$2.90M$41.48M0.00390Positive NewsLDWYLendway1.5787 of 5 stars$5.01-1.0%N/A+18.6%$8.95M$37.77M-2.0330Upcoming EarningsShort Interest ↓SUGPSU Group1.8709 of 5 stars$0.63-2.1%N/A-75.6%$8.95M$23.43M0.00N/AShort Interest ↓Gap DownWWACWorldwide Webb AcquisitionN/A$0.80-0.7%N/A-70.0%$8.34MN/A0.002,021BIAFbioAffinity Technologies0.6629 of 5 stars$0.28-3.1%N/A-83.7%$8.20M$9.36M-0.3910News CoverageEarnings ReportBIYABaiya International GroupN/A$0.60-7.8%N/AN/A$8.08M$12.81M0.0024Gap DownDRCTDirect Digital2.9156 of 5 stars$0.42-2.1%$6.00+1,342.3%-85.6%$8.04M$62.29M-0.2360News CoverageShort Interest ↑Analyst RevisionCDTGCDT Environmental Technology InvestmentN/A$0.64+5.5%N/A-82.0%$7.52M$29.76M0.00107News CoverageGap UpULYUrgent.ly2.1408 of 5 stars$5.04-1.2%$13.50+167.9%-58.3%$7.12M$142.90M-0.16753News CoverageEarnings ReportAnalyst ForecastShort Interest ↓FTFTFuture FinTech Group0.7634 of 5 stars$1.77-6.3%N/A-39.6%$6.52M$2.16M0.0070News CoverageUpcoming EarningsShort Interest ↓MSPRMSP RecoveryN/A$0.69-7.7%N/AN/A$6.15M$18.25M0.003 Related Companies and Tools Related Companies LDWY Alternatives SUGP Alternatives WWAC Alternatives BIAF Alternatives BIYA Alternatives DRCT Alternatives CDTG Alternatives ULY Alternatives FTFT Alternatives MSPR Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LICN) was last updated on 8/14/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lichen International Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Lichen International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access